> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Schedules GDUFA Reauthorization Public Meeting
- URL: https://www.fdaweb.com/fda-schedules-gdufa-reauthorization-public-meeting/
- Published: 2020-07-15T12:00:00.000Z
- Updated: 2026-09-14T16:21:11.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147209

FDA says that commissioner **Stephen Hahn** will be the keynote speaker at a 7/21 virtual public meeting seeking input on reauthorization of the Generic Drug User Fee Amendments of 2017 for FY 2023-2027 (GDUFA 3). The current GDUFA 2 authorization expires at the end of FY 2022 (9/2022). An agency [notice](http://s2027422842.t.en25.com/e/es?s=2027422842&e=352809&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=d6415fe87f074366a88e1630fd80f2c6&elqaid=13379&elqat=1&ref=fdaweb.com) says the purpose of the virtual meeting is to allow interested stakeholders an opportunity to provide their views on the program’s reauthorization. In addition to Hahn’s address, the session is to include presentations by staff and stakeholder groups and time for public comment. Meeting details and registration information are [here](https://www.fda.gov/drugs/public-meeting-reauthorization-generic-drug-user-fee-amendments-gdufa-07212020-07212020?utm%5Fcampaign=UPDATE%3A%20FDA%20Commissioner%20Hahn%20to%20speak%20at%20GDUFA%20reauthorization%20public%20meeting&utm%5Fmedium=email&utm%5Fsource=Eloqua).